SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-21-030730
Filing Date
2021-12-07
Accepted
2021-12-07 19:06:34
Documents
3
Period of Report
2021-12-07

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2480
2 ex24.htm EX-24 1100
3 ex24_001.jpg GRAPHIC 197965
  Complete submission text file 0001493152-21-030730.txt   277615
Mailing Address 1901 W. 47TH PLACE KANSAS CITY KS 66205
Business Address 1901 W. 47TH PLACE KANSAS CITY KS 66205 (913) 942-2300
Cingulate Inc. (Issuer) CIK: 0001862150 (see all company filings)

IRS No.: 863825535 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CINGULATE INC. 1901 W. 47TH PLACE KANSAS CITY KS 66205
Business Address
Brams Matthew (Reporting) CIK: 0001884361 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40874 | Film No.: 211477262